Citation Tools
Abstracts accepted for publication
Spondyloarthritis - treatment
AB0516 Characteristics and treatment response of patients with axial spondyloarthritis (axspa) starting with sulfasalazine (ssz) or tnf-inhibitor (tnfi) as the first dmard.
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- AB0516 Characteristics and treatment response of patients with axial spondyloarthritis (axspa) starting with sulfasalazine (ssz) or tnf-inhibitor (tnfi) as the first dmard.